Form 4: Kineta, Inc. Director Acquires Stock Options

Director Kimberlee C Drapkin acquired stock options in Kineta, Inc. on September 4, 2024.

Summary

• On September 4, 2024, Kimberlee C Drapkin, a director of Kineta, Inc., acquired stock options to purchase 12,500 shares of common stock.
• The exercise price of the stock options is $0.611 per share.
• The options vest in equal quarterly installments over one year following June 21, 2024, contingent upon continued service.
• The expiration date for these options is September 3, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The granting of stock options to a director is a common practice and suggests confidence in the company's future, but it's not a major event.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard practice for incentivizing and aligning the interests of company directors with those of shareholders.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in the biotechnology industry to incentivize performance and align interests with shareholders.
• The vesting schedule of one year is fairly standard.
• The exercise price is typical for stock option grants.

Stakeholder Impact

• The granting of stock options aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

Keywords

stock options, director, Kineta, Inc., beneficial ownership, Form 4, securities